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To quantify the contribution of changes in different risk factors population levels and treat-
ment uptake on the decline in CHD mortality in Denmark from 1991 to 2007 in different
socioeconomic groups.
Design
We used IMPACTSEC, a previously validated policy model using data from different popula-
tion registries.
Participants
All adults aged 25–84 years living in Denmark in 1991 and 2007.
Main outcome measure
Deaths prevented or postponed (DPP).
Results
There were approximately 11,000 fewer CHD deaths in Denmark in 2007 than would be
expected if the 1991 mortality rates had persisted. Higher mortality rates were observed in
the lowest socioeconomic quintile. The highest absolute reduction in CHD mortality was
seen in this group but the highest relative reduction was in the most affluent socioeconomic
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quintile. Overall, the IMPACTSEC model explained nearly two thirds of the decline in.
Improved treatments accounted for approximately 25% with the least relative mortality
reduction in the most deprived quintile. Risk factor improvements accounted for approxi-
mately 40% of the mortality decrease with similar gains across all socio-economic groups.
The 36% gap in explaining all DPPs may reflect inaccurate data or risk factors not quantified
in the current model.
Conclusions
According to the IMPACTSEC model, the largest contribution to the CHD mortality decline in
Denmark from 1991 to 2007 was from improvements in risk factors, with similar gains across
all socio-economic groups. However, we found a clear socioeconomic trend for the treat-
ment contribution favouring the most affluent groups.
Introduction
Coronary heart disease (CHD) mortality has declined substantially during recent decades in
Denmark and other Western countries [1]. CHD, however, remains one of the leading causes
of death, morbidity and economic burden for the Danish health care systems and in the world
[2,3]. This decline has been attributable to decreases in prevalence of risk factors for CHD and
to improvements of medical treatment and treatment uptake [4–8]. Some studies have
reported that population-level changes to risk factors such as smoking, cholesterol, hyperten-
sion, physical inactivity, obesity and diabetes mellitus are responsible for 45% to 75% of the
decline in CHD mortality, while treatments improvement could be responsible for 25% to 50%
of the decline [4–6].
Previous studies have demonstrated that the decrease in CHD mortality has not been
equally beneficial for all socioeconomic groups [9,10]. The most deprived groups have the
highest reductions in CHD mortality in absolute numbers whereas the most affluent group
benefit from the highest reductions in relative terms. This has led to an overall lower CHD
mortality but a relative bigger gap between the affluent and deprived groups. Studies from UK
have shown that inequality in health also has significant economic costs due to loss of produc-
tion, loss of tax payment and higher expenses to welfare and health care (https://heartuk.org.
uk/files/uploads/Bridging_the_Gaps_Tackling_inequalities_in_cardiovascular_disease.pdf).
Denmark, considered as one of the most socioeconomic equal societies in the western
world with the lowest Gini coefficient in the study period (http://dx.doi.org/10.1787/
420515624534 and http://dx.doi.org/10.1787/422066332325), has a taxpayer funded health
care system given free access to most of the health care services. Despite of this it has been
shown that there are socioeconomic differences in the state of health in Denmark and in
uptake of different medical treatments [11,12].
In this study, we aim to quantify the contribution of changes in different population risk
factors and treatment uptake on CHD mortality in Denmark from 1991 to 2007 in different
socioeconomic groups.
Methods
The IMPACT model is a deterministic, cell-based model that has been developed to help
explain the contribution of the change in different risk factors and treatment uptakes on CHD
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mortality [4,6]. The model uses information from many different data sources on patient num-
bers, uptake of evidence based medical treatments and the case fatality reduction for each
treatment. Also, the model includes prevalence of risk factors from two time points in the cur-
rent study, 1991 and 2007, and uses mortality risk from each risk factor. Thus, the model calcu-
lates how much changes in treatments and risk factor prevalence has contributed to the
change in CHD mortality in the study period. Recently the IMPACTsec model has been devel-
oped to also quantify the impact of socioeconomic inequalities in risk factor prevalence and
treatment uptake [9,10] on CHD mortality.
The extended IMPACTsec model also included all the major risk factors for CHD: smok-
ing, systolic blood pressure, total cholesterol, body mass index (BMI), diabetes, physical inac-
tivity; plus medical and surgical treatments currently in use in nine patient groups [9,10].
Population
The Danish IMPACTsec model included the Danish population between 25–84 years in 1991
and 2007. The population was divided into 60 different groups based on gender, six different
age-groups (25–34, 35–44, 45–54, 55–64, 65–74 and 75–84), and five socioeconomic-level
groups based on quintiles of personal financial income.
Information of population counts was obtained from the Danish Central Office of Civil
Registration which contains complete information on vital status, date of birth and a unique
personal 10-digit code that makes it possible to merge information from different registers on
an individual level [13]. Financial income data was obtained from Statistic Denmark. Based on
gender and age specific personal tax-income information, the population was divided into
socioeconomic quintiles (secq groups) ranged from the most affluent to the most deprived.
Deaths prevented or postponed
The numbers of CHD deaths expected in 2007 were calculated by multiplying the age and sex-
specific CHD mortality in 1991 by the relevant population counts for 2007. Summing over all
strata then yielded the expected number of deaths in 2007 had mortality rates remained
unchanged.
The difference between the number of expected and observed deaths then represented the
decline in mortality or the total number of CHD deaths prevented or postponed to be
explained (DPPs) by the combined changes in risk factor levels and treatment uptake between
1991 and 2007.
Data on CHD deaths (1991: International Classification of Diseases (ICD)-8 code 410–414
and 427; 2007: ICD-10 code I20-25 and I50) were obtained from The Danish Cause of Death
Registry
Disease groups and treatments uptake
The Danish IMPACTsec model includes nine mutually exclusive disease groups: 1) ST eleva-
tion acute myocardial infarction (STEMI), 2) Non-ST elevation acute myocardial infarction
(NSTEMI), 3) previous myocardial infarction eligible for secondary prevention, 4) previous
coronary artery bypass grafting surgery (CABG) or Percutaneous Coronary Intervention
(PCI) eligible for secondary prevention, 5) stable angina pectoris, 6) hospital admission for
congestive heart failure (CHF), 7) CHF treated in the community, 8) patients eligible for pri-
mary prevention of hypercholesterolemia, and 9) patients eligible for primary prevention of
hypertension.
When individuals had more than one cardiac diagnosis, they were categorized into only
one disease-group representing the highest mortality risk.
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For each disease group we specified relevant treatments. To quantify mortality risk reduc-
tion due to treatment we used the number of eligible patients for each of the nine mutually
exclusive disease-groups, the change in treatment uptake rate for relevant treatments in the
two index years and the case fatality reduction for each treatment.
Example: Net effects for treatments
Calculating net effects for aspirin use in STEMI cases in men aged 55–64 in the most
deprived quintile
With an estimated total of 147 men aged 55–64 with STEMI in the most deprived quintile,
uptake rate in 2007, 97% and uptake rate in 1991, 14%, a relative risk reduction of 23%, a one-
year case fatality rate of 34%, and 100% compliance, the total number of DPPs for aspirin was:
Patient numbers × (treatment uptake2007—treatment uptake1991) × compliance × relative
mortality reduction × one year case fatality:
147 x ð97%   14%Þ x 1 x 23% x 34% ¼ 9:5 DPPs
This calculation was repeated for each age-gender-secq group and we incorporated a Mant
and Hicks adjustment for multiple medications within each patient group. (For a detailed
overview for treatments for each disease group and the Mant and Hicks adjustment, (please
see S1 Technical Appendix).
Information of hospital admissions for CHD diagnoses (STEMI, NSTEMI and CHF), was
obtained from The Danish National Patient Registry. Number of patients in the community
with CHF and angina pectoris and patients eligible for secondary prevention therapy were also
obtained from Danish National Patient Registry and was defined as persons with a hospital
admission for the relevant diagnosis within the previous 11 years.
Number of patients eligible for primary therapy (hypercholesterolemia and hypertension)
was based on information from cohort studies Copenhagen City Heart Studies (CCHS) 3 and
4 [14] and was defined as the proportion of persons with either self-reported hypercholesterol-
emia/hypertension and/or measurement of a serum-total cholesterol > 5 mmol/l or a systolic
blood pressure > 140 mmHg.
Treatment uptake of pharmacological treatment in 2007 was obtained from The Danish
Medical Agency Registry. Since there was no national prescription registry in Denmark in
1991 we used the regional prescription registry from Funen [15] to estimate treatment uptake
rates for 1991 and assumed that this was representative for the whole country. There is no
Danish registry with data on uptake of in-hospital pharmacological treatment so we performed
a survey among patients discharged with diagnoses of acute coronary syndrome (ACS) and
CHF. Information on invasive treatment with CABG and PCI was obtained from the National
Patient Registry. One year case fatality rates of the diseases and relative risk reduction for each
treatment was obtained from previous observational and randomized studies similar with
other IMPACTsec models [9,10].
Risk factors
In the Danish IMPACTsec model, we included six different major cardiovascular risk factors.
For risk factors measured in a continuous scale (serum cholesterol, blood pressure and BMI),
we used a regression based approach using independent age-sex specific coefficients for mor-
tality benefit for each unit of change in the risk factors from the base year to the final year.
Example: Estimation of DPPs from risk factor changes using regression method
Among women aged 55–64 in the most deprived quintile the number of expected death
was 176 in 2007. Mean total cholesterol in this group fell by an estimated 1.28 mmol/l (from
7.04 in 1991 to 5.76 in 2007). The largest meta-analysis reports an estimated age-sex specific
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reduction in mortality of 35% for every 1 mmol/l reduction in total cholesterol [16], generating
a logarithmic coefficient of -0.431 (i.e. natural logarithm of (1–0.35)). The subsequent reduc-
tion in CHD deaths due to cholesterol reduction between 1991 and 2007 was then estimated
as:
ð1   ðexponential ðregression coefficient  absolute changeÞÞÞ  expected deaths in 2007 :
ð1   ðexponential ð  0:431 1:28ÞÞÞ  176 ¼ 75 DPPs
This calculation was then repeated for each age-gender-secq group.
For dichotomous risk factors (smoking, physical inactivity and diagnosed diabetes mellitus)
we used a population attributable risk fraction (PARF) approach using independent age-sex
specific estimates for relative risks. PARF, which can be interpreted as the proportion by
which the mortality rate from CHD would be reduced if the exposure was eliminated [17], was
calculated as:
PARF ¼ ½P  ðRR   1Þ = ½1þ P  ðRR   1Þ
Where P is the prevalence of the risk factor and RR is the relative risk for CHD mortality
associated with risk factor presence.
Example: Estimating DPPs from risk factor change–PARF approach for binary risk factors
The prevalence of diabetes among men in the most deprived quintile aged 65–74 years was
4.3% in 1991 and 8.2% in 2007. Assuming a relative risk of 1.86, the PARF at the national level
for men aged 65–74 was 0.036 in 1991 and 0.066 in 2007.
The DPPs was therefore:
expected CHD deaths in 2007 ðPARF1991   PARF2007Þ :
874 ð0:036   0:066Þ ¼   26 DPPs
A negative sign for the DPPs denotes deaths brought-forward due to the increase in diabe-
tes prevalence. The calculation was then repeated for each age-gender-secq group.
For calculation of the joint mortality benefits from risk factors, we used a cumulative (rather
than an additive) risk reduction approach (see S1 Technical Appendix).
Information on risk factors was achieved through population cohort studies CCHS 3 and 4
described in details elsewhere [14]. Briefly, the cohort study invited over 20.000 men and
women randomly drawn from Copenhagen Population Register in 1976 to participate with the
purpose to describe the distribution of cardiovascular risk factors in the population and to
examine these risk factors relation to morbidity and mortality. At the following examination
in 1981–83, 1991–94 (CCHS 3) and 2002–3 (CCHS 4) the study population was supplemented
with the youngest age groups while all previous participants alive and living in Denmark were
invited. All subjects filled in a self-administered questionnaire (concerning e.g. smoking habits
and physical inactivity), had a physical examination (BMI, blood pressure), and had a non-
fasting venous blood sample (lipids). As we only had risk factors measurements for 1993 and
2003 we calculated gradients to estimate values for 1991 and 2007. Data on prevalence of DM
was obtained from The Danish National Patient Registry.
Sensitivity analysis
We calculated 95% empirical intervals around the model output (that is, deaths prevented or
postponed) by using Monte Carlo simulation, as in health economic evaluation studies [18].
This calculation involved replacing all fixed input parameters used in the model by appropriate
probability distributions and repeatedly recalculating the model output with values sampled
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from the defined input distributions. We used the Excel add-in Ersatz software (www.epigear.
com) to do 10,000 runs to determine the 95% uncertainty intervals of the deaths prevented or
postponed (2.5th and 97.5th centile values corresponding to the lower and upper limits) [10].
To control for possible selection bias regarding data collection from the cohort study with
repeated examinations, for sensitivity analyses we also substituted estimates for risk factors
fraction obtained from the CCHS cohort studies with estimates from cross sectional popula-
tion surveys Dan-MONICA III (1991) and Health 2006 (2006–7) [19].
DPPs explained by the model could be positive (i.e., deaths averted) or negative (i.e., addi-
tional deaths in 2007 relative to 1991). Any differences between the DPPs explained by the
model and the total DPPs for each secq group were assumed to reflect either imprecision in
our model parameters or omission of other, unmeasured risk factors [9,10].
More details on the IMPACTsec model methodology, including the data sources for this
study are described in details in S1 Technical Appendix.
Results
As expected, CHD mortality rates were higher in males than females (Table 1). From 1991 to
2007 we observed a decline of nearly 75% in CHD mortality (indirect age standardization) for
the age group 25–84 years in Denmark for both men and women. A decline was seen for all
socioeconomic groups but differed somewhat in magnitude across gender-age-secq groups. As
shown in Fig 1, the largest absolute reduction in mortality was among the most deprived
women where the death rates were extremely high in 1991 compared to the other quintiles.
The relative CHD mortality reductions ranged from nearly 80% to below 70% and, with the
notable exception of the most deprived women, was overall higher in the more affluent for
both females and males (Table 1).
The Danish IMPACTsec model could explain almost two third (95% CI 59.7–68.6%) of
all DPPs. Thus, 23.8% (95% CI 20.9–27.5%) of the 11,111 DPPs could be explained by
higher treatment uptake whereas the contribution of risk factors could explain 40.1% (95%
CI 37.1–42.9%, Tables 2 and 3). The best model fit was in the middle sec quintile explaining
77% of all DPPs whereas it could only explain 53% and 61% in the most deprived and afflu-
ent sec quintile, respectively, (please see S1 Technical Appendix). The largest contribution
of treatment was found within in-hospital CHF (4.4%) and CHF in the community (6.2%)
(Table 2). Among the risk factors the largest contribution was from reduction in prevalence
of hypercholesterolemia (24.1%) and smoking (9.9%). Lower systolic blood pressure and
less physical inactivity contributed with 5.2% and 3.9%, respectively. Increase in BMI and
prevalence of DM resulted in an increase of CHD mortality of 1.0% and 2.1%, respectively
(Table 3).
The proportion of DPPs explained by the model differed between secq groups. Better treat-
ment contributed to approximately 25% in the most affluent secq groups and less than 20% in
the most deprived group (Table 2). Improvement in risk factors could explain the relative
highest proportion for the middle SEC group and less for the most deprived and affluent secq
groups. The relative contribution from reduction in cholesterol level (minus treatment) was
highest in the most deprived quintile compared to the most affluent quintile, whereas for
smoking and hypertension there was no consistent difference between the five secq groups
(Table 3).
Substituting risk factor data from cohort studies (CCHS 3 and 4) to data from survey stud-
ies (Dan MONICA III and Health 2006) lead to different results for some of the risk factors.
Prevalence of smoking was higher in the surveys and could explain 17.6% of DPPS (vs 9.9% in
the original model) whereas differences in cholesterol levels and especially systolic blood
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pressure were lower. Reduction in cholesterol in the surveys could explain 16.5% of DPPs (vs
24.1% in the original model). In the cross sectional surveys blood pressure measurements
increased during the study period and therefore contributed to an increase in DPPs (-11.6% vs
6.3% in the original model). Other risk factor estimates were similar, giving a total explanation
of 30.6% (vs 40.1% of the original model) of the DPPs. No substantial changes were seen
regarding the differences between socioeconomic groups when compared to data from the
CCHS cohorts. Data are shown in S1 Technical Appendix.
Table 1. Coronary heart disease mortality rates in Denmark in 1991 and 2007, for the whole nation and divided into socio-economic quintiles. Also calculated num-
bers of deaths prevented or postponed (DPPs) in 2007 if the death-rates had been the same in 2007 as in 1991.
Year Denmark Most Affluent secq2 secq3 secq4 Most Deprived
Male
Population (000s) 1991 1555 311 311 311 311 311
2007 1700 340 340 340 340 340
Observed CHD deaths 1991 8272 1098 1425 1587 1890 2273
2007 2421 253 392 434 598 745
Age-standardised rate (per 100,000) 1991 532 353 458 510 608 730
2007 138 73 114 126 170 208
Expected deaths† 2007 9396 1239 1610 1801 2166 2580
DPPs‡ 1991–2007 6975 986 1219 1367 1568 1836
Absolute mortality rate reduction (per 100,000) 1991–2007 394 280 344 384 438 522
Relative mortality rate reduction (%) 1991–2007 74.2 79.6 75.7 75.9 72.4 71.1
Female
Population (000s) 1991 1647 329 329 329 329 329
2007 1760 352 352 352 352 352
Observed CHD deaths 1991 5597 741 889 983 1072 1913
2007 1462 158 253 330 340 381
Age-standardised rate (per 100,000) 1991 340 225 270 298 325 581
2007 89 48 77 100 103 116
Expected deaths† 2007 5575 728 882 992 1083 1890
DPPs‡ 1991–2007 4135 575 638 669 744 1509
Absolute mortality rate reduction (per 100,000) 1991–2007 251 177 193 198 222 465
Relative mortality rate reduction (%) 1991–2007 74.1 79.0 72.3 67.5 68.7 79.8
Total
Population (000s) 1991 3202 641 641 641 641 641
2007 3461 692 692 692 692 692
Observed CHD deaths 1991 13879 1840 2316 2572 2964 4187
2007 3870 408 638 759 939 1128
Age-standardised rate (100,000) 1991 433 287 361 402 463 654
2007 112 60 95 112 136 161
Expected deaths† 2007 14981 1969 2494 2794 3251 4473
DPPs‡ 1991–2007 11111 1561 1857 2036 2313 3345
Absolute mortality rate reduction (per 100,000 1991–2007 321 227 266 290 327 493
Relative mortality rate reduction (%) 1991–2007 74.2 79.3 74.4 72.9 71.1 74.8
 Socioeconomic quintiles based on financial income, with the most affluent group number 1 and the most deprived number 5.
† Expected deaths: CHD deaths expected in 2007 had 1991 CHD rates remained.
‡ DPPs, deaths prevented or postponed. DPPs: expected–observed deaths in 2007.
https://doi.org/10.1371/journal.pone.0194793.t001
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Fig 1. Change in CHD mortality in Denmark 1991–2007 for males and female.
https://doi.org/10.1371/journal.pone.0194793.g001
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Discussion
We found a dramatic reduction in CHD deaths in Denmark from 1991 to 2007, age standard-
ized mortality rates fell by nearly 75% in both men and women. In absolute numbers the
decline was most pronounced in the most deprived groups but the relative reduction was gen-
erally highest among the most affluent. We found gender differences as the age-standardized
death rates in 2007 versus 1991 among the most deprived groups became nearly 1/4 and 1/5
for men and women respectively. Furthermore, whereas male/female ratios were nearly similar
in 1991 they became 2 to 1 in 2007. This most likely reflects multiple contributors. However,
we found no substantial gender differences in change in treatment uptake or risk factor preva-
lences. The ratio shift might therefore perhaps be partly explained by risk factors not included
in the model. Overall, he IMPACTsec model could explain approximately 64% of the DPPs
with the biggest contribution attributable to improvements in the prevalence of risk factors.
Approximately two thirds of the explained DPPs resulted from contribution from risk fac-
tors and one third from treatment uptake, much as in previous analyses [5,7,8]. Approximately
one third of the CHD mortality reduction could not be explained, perhaps reflecting inaccu-
rate data or risk factors not quantified in the current model.
Table 2. Number of coronary heart disease deaths prevented or postponed from 1991 to 2007 due to changes in treatment uptake in different patient groups in
Denmark, stratified by socioeconomic quintiles.
Patient Groups Deaths Prevented or Postponed
N Percenta Lower limit Percenta Upper limit n Most Affluent n secq2 n secq3 n secq4 n Most Deprived
STEMI 127 73 233 19 24 25 30 29
(%)b (1.1) (0.7) (2.1) (1.2) (1.3) (1.2) (1.3) (0.9)
NSTEMI 181 98 347 32 36 39 39 42
(%)b (1.6) (0.9) (3.1) (2.1) (1.9) (1.9) (1.7) (1.2)
Secondary prevention post MI 412 329 519 62 78 85 93 93
(%)b (3.7) (3.0) (4.7) (4.0) (4.2) (4.2) (4.0) (2.8)
Secondary prevention post
revascularisation
192 149 247 31 36 41 43 42
(%)b (1.7) (1.3) (2.2) (2.0) (1.9) (2.0) (1.9) (1.3)
Chronic stable angina 242 193 306 36 47 51 55 54
(%)b (2.2) (1.7) (2.8) (2.3) (2.5) (2.5) (2.4) (1.6)
Heart failure–hospital 420 357 506 46 68 87 102 117
(%)b (3.8) (3.2) (4.6) (3.0) (3.6) (4.3) (4.4) (3.5)
Heart failure–community 629 533 737 85 109 128 148 159
(%)b (5.7) (4.8) (6.6) (5.4) (5.9) (6.3) (6.4) (4.8)
Hypertension treatment 114 60 198 21 21 22 25 24
(%)b (1,0) (0.5) (1.8) (1.3) (1.1) (1.1) (1.1) (0.7)
Hyperlipidemia treatment (statins) 326 168 593 63 65 66 68 63
(%)b (2.9) (1.5) (5.3) (4.0) (3.5) (3.3) (3.0) (1.9)
A: Total treatment contribution 2,642 2,323 3,058 395 484 545 604 622
(%)b (23.8) (20.9) (27.5) (25.3) (26.1) (26.8) (26.1) (18.6)
a 95% uncertainty interval corresponds to the lower (2.5th percentile) and upper (97.5th percentile) limits of the uncertainty analysis. These are shown in italics to
indicate range around the central estimate of percent of DPPs explained.
b Numbers in brackets are the relative contribution of total DPPs for the treatment of the respective disease-group.
Abbreviations: MI, myocardial infarction; NSTEMI, non-ST-segment elevated myocardial infarction; secq, socio-economic quintiles; STEMI, ST-segment elevated
myocardial infarction.
https://doi.org/10.1371/journal.pone.0194793.t002
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There have been major improvements in the CHD treatments in the last three decades,
including statins, as both primary and secondary prevention. Also, pharmacological improve-
ments of CHF treatment and systematically follow- up for CHF patients in ambulatory clinics
throughout Denmark has ensured higher treatment uptakes and persistence to treatment for
this patient group. Moreover, coronary revascularization (PCI and CABG) has been widely
used in Denmark for both acute treatment for myocardial infarction and elective treatment for
angina. These improvements are reflected in our results showing that especially improvements
in CHF treatment and higher use of statins contributed to the reduction of CHD mortality.
Almost twice as many deaths were prevented or postponed in the most deprived quintiles
compared with the most affluent quintile (1901 DPPs vs 1080 DPPs). However, the mortality
rate in the base year was much higher in the most deprived group, especially for women and
the relative mortality decline was most pronounced in the most affluent group (79.6% vs
71.1%). This may be explained by a bigger contribution from better treatments in the most
affluent. In spite of the fact that the health care system in Denmark is financed through taxes
and not depended on private health insurances or self-payment, these findings indicate that
even in a collectively financed health care system, the most affluent patients may be better at
taking advantage of the treatment offered. This is supported by previous studies showing that
the initiation of invasive treatments and preventive pharmacological post-AMI treatment was
higher for patients with the highest financial income [11,12]. This may be partly because basic
medication costs are not fully covered by the public health insurance system and partly because
patients from lower socio-economical groups have more difficulties in sticking to a prolonged
medical treatment.
The highest contribution to DPPs among risk factors was reduction in hypercholesterol-
emia and smoking whose benefits were similar across all socioeconomic groups. The
Table 3. Number of coronary heart disease deaths prevented or postponed from 1991 to 2007 due to changes in risk factor prevalence in Denmark, stratified by dep-
rivation quintiles.
Risk Factors Deaths prevented or postponed
N Percent Lower Limitb Percent Upper Limitb n Most Affluent n secq2 n secq3 n secq4 n Most Deprived
Current smoking 1,105 919 1288 146 249 226 220 264
(%)a (9.9) (8.3) (11.6) (9.3) (13.4) (11.1) (9.5) (7.9)
Physical inactivity 437 331 558 35 54 61 133 154
(%)a (3.9) (3.0) 5.0 (2.2) (2.9) (3.0) (5.7) (4.6)
Systolic blood pressure, mmHgc 581 397 755 51 45 346 159 −20
(%)a (5.2) (3.6) (6.8) (3.3) (2.4) (17.0) (6.9) (-0.6)
Total cholesterol, mmol/ld 2,679 2,531 2,815 348 435 479 561 856
(%)a (24.1) (22.8) (25.3) (22.3) (23.4) (23.5) (24.3) (25.6)
Body mass index −113 -169 -55 −6 −26 −35 −24 −23
(%)a (−1.0) (-1.5) (-0.5) (-0.4) (-1.3) (-1.7) (-1.0) (-0.7)
Diabetes mellitus −231 -274 -188 −13 −25 −46 −65 −82
(%)a (−2.1) (-2.5) (-1.7) (-0.8) (-1.4) (-2.3) (-2.8) (-2.4)
Total risk factors contribution 4,453 4,119 4,766 561 731 1,032 986 1,150
(%)a (40.1) (37.1) (42.9) 36.0 39.4 50.7 42.6 34.4
a Numbers in brackets are the relative contribution of total DPPs for the treatment of the respective disease-group.
b 95% uncertainty interval corresponds to the lower (2.5th percentile) and upper (97.5th percentile) limits of the uncertainty analysis.
cAfter subtracting DPPs due to hypertension treatment in primary prevention.
dAfter subtracting DPPs due to cholesterol lowering treatment in primary prevention.
Abbreviations: DPP, Death prevented or postponed, secq, socio-economic quintile.
https://doi.org/10.1371/journal.pone.0194793.t003
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contribution of other risk factors did not show any consistent social gradient. In 2004, Den-
mark promoted legislation against use of industrial produced trans fatty acids in the food
industry and this may have had an indirect beneficial effect on the cholesterol level and also
helped to explain the big mortality fall in the most deprived group, assuming that before the
ban this group could have had the highest intake of trans fatty acids. Thus, previous studies in
UK have indicated that a high consumption of (primarily industrial) trans fatty acids was asso-
ciated with social disadvantage before a voluntary reformulation of use of industrial trans fatty
acids. After reformulation there was a significant reduction of trans fatty acids and the associa-
tion to social disadvantage [20]. A similar effect may explain the reduction of smoking where a
ban was enacted in 2007 but may have had some influence on smoking habits in the preceding
years.
Overall, the contribution to DPPs was highest among risk factors. Thus, the contribution of
smoking reduction was more than three times that of the overall treatment of myocardial
infarction (9.5% vs 2.7%, see Tables 2 and 3). Moreover, since the treatment uptakes in Den-
mark are high the potential for further reduction in coronary mortality seems more likely to
come from further improvements in lifestyle and risk factors than in improvement of treat-
ment uptake. This may also be less expensive and as mentioned above this may also benefit all
socioeconomic groups.
This study had many strengths. We used an epidemiologic model (IMPACTsec) that has
been applied in a number of countries and found to be valid in explaining the change in coro-
nary mortality. We predominantly used registries with very high quality of individualized data
on diagnosis, treatments and financial income and it was possible to merge information on an
individual level from different registries using a unique personal code. Thus, we could avoid or
minimize the risk of overlap between disease- or treatment groups ensuring that persons only
were included in one of the nine mutually independent disease-groups.
Some limitations also need to be acknowledged. First of all, we could not explain one third
of the DPPs. Previous IMPACT models used in other countries have explained a higher pro-
portion of the DPPs compared to the Danish IMPACTsec model [4–10]. In our model, how-
ever, treatment uptake rates and risk factor decrease was comparable to other countries. The
main difference in Denmark compared to previous studies was that the decrease in CHD mor-
tality was so pronounced resulting in lower relative numbers; in other words the Danish
IMPACTsec model was not able to explain the extra CHD mortality reduction that was seen in
Denmark.” This may be because data of e.g. risk factors or in-hospital treatments were not
accurate or because unaccounted factors might have played a role, for example changes in
trans-fat intake at the population level In Denmark, we do not have any registry data of com-
munity diagnosis and therefore we used data from hospital registries on e.g. DM and angina.
Also, we calculated the prevalence in the community of congestive heart failure and number of
persons eligible for secondary prevention following ACS from the hospital registry. We assume
that most persons with these diagnoses would have had a hospital contact during the previous
11 years. We did not have any nationwide data of in-hospital treatment and therefore per-
formed a survey including 500 randomly chosen patients with myocardial infarction and CHF
within one (of five) region of Denmark and assumed that this was representative for the gen-
eral in-hospital treatment for the whole country. With this limited number there were some of
the age-gender-SEC groups that were very small but to optimize the data information we cal-
culated gradients (S1 Technical Appendix). For 1991, we did not have a national prescription
registry for medical treatment in the community so we used data from county of Funen and
used the same methods as mentioned above. There is no registry with national representative
information on the prevalence of risk factors but we used data from a large cohort study with
repeating measurements for each decade. This means that we compare nearly the same
Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark
PLOS ONE | https://doi.org/10.1371/journal.pone.0194793 April 19, 2018 11 / 13
population which could contribute to a false decline in blood pressure due to higher mortality
among those with high blood pressure. We did not include information of other risk factors
on e.g. diet, alcohol, trans fatty acids but their effect is partially mediated through some of the
risk factors included in the model. Some treatments (CPR and cardiac rehabilitation) were
also omitted from this IMPACTsec model but we assume that this may be compensated for by
including data on pharmacological treatment or that the differences of treatment uptake was
limited between base year and final year. Moreover, the data structure did not allow us to
examine interaction or effect modification since data originates from many different surveys
and registers, for further details please see S1 Technical Appendix.
Using risk factor data from other sources did reduce the numbers of DPPs explained by the
model. This was mainly because these data indicated an increase in mean systolic blood pres-
sure during the study period explaining -11.6% DPPs vs +6.3% in the original model. Other
risk factor numbers were more similar. As mentioned above, there may be some selection bias
using cohort data since participants with hypertension from the base year may not participate
in the final year because of morbidity or mortality. On the other hand blood pressure levels in
the surrounding areas/countries usually comparable to Denmark was decreasing in the same
period and also the surveys did not have any data from the oldest age group.
Conclusions
The IMPACTSEC model suggests that the largest contribution to the CHD mortality decline in
Denmark from 1991 to 2007 was from improvements in risk factors across all socioeconomic
groups. However, we found a clear socioeconomic trend for the treatment contribution
favouring the most affluent groups.
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